For patients not experiencing somnolence, clinical response was observed in 47% of patients receiving duloxetine and 27% patients on placebo.
Nende patsientide hulgast, kel ei ilmnenud unisust, vaadeldi ravivastust 47% - l duloksetiini saanud patsientidel ja 27% - l platseeboga ravitud patsientidel.